194 related articles for article (PubMed ID: 19963078)
41. Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.
Juréen P; Werngren J; Toro JC; Hoffner S
Antimicrob Agents Chemother; 2008 May; 52(5):1852-4. PubMed ID: 18316515
[TBL] [Abstract][Full Text] [Related]
42. A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.
Yadon AN; Maharaj K; Adamson JH; Lai YP; Sacchettini JC; Ioerger TR; Rubin EJ; Pym AS
Nat Commun; 2017 Sep; 8(1):588. PubMed ID: 28928454
[TBL] [Abstract][Full Text] [Related]
43. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
Mphahlele M; Syre H; Valvatne H; Stavrum R; Mannsåker T; Muthivhi T; Weyer K; Fourie PB; Grewal HM
J Clin Microbiol; 2008 Oct; 46(10):3459-64. PubMed ID: 18753350
[TBL] [Abstract][Full Text] [Related]
44. [Determining drug resistance of the clinical strains of Mycobacterium tuberculosis to pyrazinamide].
Nizova AV; Stepanshina VN; Maĭskaia NV; Mironova RI; Bogun AG; Domotenko LV; Morozova TP; Shemiakin IG
Mol Gen Mikrobiol Virusol; 2008; (4):23-6. PubMed ID: 19172875
[TBL] [Abstract][Full Text] [Related]
45. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
[TBL] [Abstract][Full Text] [Related]
46. Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico.
Cuevas-Córdoba B; Xochihua-González SO; Cuellar A; Fuentes-Domínguez J; Zenteno-Cuevas R
Infect Genet Evol; 2013 Oct; 19():330-4. PubMed ID: 23321280
[TBL] [Abstract][Full Text] [Related]
47. Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
Vats C; Dhanjal J; Goyal S; Gupta A; Bharadvaja N; Grover A
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S14. PubMed ID: 25708048
[No Abstract] [Full Text] [Related]
48. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
49. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
Ramirez-Busby SM; Valafar F
Antimicrob Agents Chemother; 2015 Sep; 59(9):5267-77. PubMed ID: 26077261
[TBL] [Abstract][Full Text] [Related]
50. Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.
Tan Y; Hu Z; Zhang T; Cai X; Kuang H; Liu Y; Chen J; Yang F; Zhang K; Tan S; Zhao Y
J Clin Microbiol; 2014 Jan; 52(1):291-7. PubMed ID: 24131688
[TBL] [Abstract][Full Text] [Related]
51. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
[TBL] [Abstract][Full Text] [Related]
52. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.
Mirabal NC; Yzquierdo SL; Lemus D; Madruga M; Milián Y; Echemendía M; Takiff H; Martin A; Van der Stuyf P; Palomino JC; Montoro E
J Clin Microbiol; 2010 Aug; 48(8):2729-33. PubMed ID: 20554826
[TBL] [Abstract][Full Text] [Related]
54. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.
Sun Z; Scorpio A; Zhang Y
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938
[TBL] [Abstract][Full Text] [Related]
55. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
[TBL] [Abstract][Full Text] [Related]
56. The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis.
Mahmood N; Bhatti S; Abbas SN; Shahid S; Nasir SB
Biotechnol Appl Biochem; 2022 Oct; 69(5):2195-2204. PubMed ID: 34731907
[TBL] [Abstract][Full Text] [Related]
57. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
Scorpio A; Zhang Y
Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
[TBL] [Abstract][Full Text] [Related]
58. Microarray-based pncA genotyping of pyrazinamide-resistant strains of Mycobacterium tuberculosis.
Denkin S; Volokhov D; Chizhikov V; Zhang Y
J Med Microbiol; 2005 Dec; 54(Pt 12):1127-1131. PubMed ID: 16278424
[TBL] [Abstract][Full Text] [Related]
59. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N.
Junaid M; Khan MT; Malik SI; Wei DQ
J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017
[TBL] [Abstract][Full Text] [Related]
60. A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.
Aono A; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
J Microbiol Methods; 2018 Nov; 154():52-54. PubMed ID: 30316980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
